 Home > Chemicals Industry > Rubber Plastic News > Evonik signs global exclusive license agreement to expand biodegradable implant-grade biomaterials

Evonik signs global exclusive license agreement to expand biodegradable implant-grade biomaterials

 Last Update: 2022-08-21
 Source: Internet
 Author: User

Tags

dr reddys laboratories

long novel

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Evonik, the world's leading supplier of biomaterials for implantable medical devices, announced the signing of an exclusive global license agreement with ITV Denkendorf Produktservice (ITVP), a German leader in the development and manufacture of medical textile materials

Signed an exclusive worldwide license agreement with ITVP, Germany

Introduces new polymer platform to enable novel wound closure and vascular devices with improved functionality

Build RESOMER® to be the largest and most diverse product group of functional biomaterials for implantable device manufacturing

Under the agreement, Evonik will launch a new glycolide-based polymer platform for monofilament and multifilament production, further expanding its portfolio of market-leading RESOMER® implant-grade biodegradable polylactic acid

What are the advantages of the new polymer platform?

The world's largest and most diverse portfolio of biomaterials

A range of colorless or purple homopolymer (PGA), copolymer (PGLA) and block copolymer (PGA-CL and PGA-TMC) grades will be added to the standard RESOMER® product catalog

Together with other recently launched innovative biomaterials, including PLA-PEG copolymers, filaments for 3D printing, and surface modification technologies, the RESOMER® portfolio is now the largest and most diverse biomaterial portfolio in the world , can be widely used in plastic surgery, blood vessels and wound closure and other fields

Precise customization based on application needs

The platform develops polymer products that can be precisely tailored to meet target application requirements in terms of mechanical properties (tensile strength, low flexural stiffness, or elasticity) and degradation rates (from less than one month to two months or more)

1+1>2 strength cooperation

Evonik will leverage the extensive technical capabilities of its polymer processing and advanced applications laboratories in the US, Germany and China, as well as the expertise of ITVP, to support customers in the development, analytical testing and scale-up of fabric-based products

"By expanding its polymer portfolio for textile-based medical devices, Evonik has further strengthened its position as the global partner of choice for medical device companies

- said Dr.
Jean-Luc Herbeaux, head of the Evonik Healthcare business line

"The agreement will leverage Evonik and ITVP's strength and application expertise in polymer design and synthesis to provide medical device companies with high-quality functional biomaterials to enhance the quality and performance of their fabric-based implantable medical devices
.
" ITVP Managing Director Dr.
Sven Oberhoffner said: "We look forward to a long-term partnership with Yingchuang to meet emerging customer needs for implantable devices in wound closure and soft tissue applications
.
"

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.